Literature DB >> 17897636

An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.

Yuanyuan Zha1, Thomas F Gajewski.   

Abstract

Cbl family ubiquitin ligases act as key negative regulators of TCR signaling. Knockout mice lacking Cbl-b and c-Cbl show augmented T cell activation and CD28-independent IL-2 production. In order to study Cbl function directly in post-thymic T cells, a DN Cbl adenovirus was generated for transduction of T cells from Coxsackie/adenovirus receptor (CAR) transgenic (Tg) mice. We show that dominant negative (DN) Cbl-transduced CD4+ T cells exhibited enhanced IL-2 production upon TCR/CD28 engagement compared with empty adenoviral vector-transduced cells. This augmentation was reflected at both IL-2 mRNA and protein level, and correlated with increased protein phosphorylation of Vav, Akt, ERK, and p38MAPK. Our results indicate that introduction of dominant negative Cbl can potentiate activation of post-thymic CD4+ T cells, which argues for development of strategies to interfere with Cbl function as a method of immunopotentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897636      PMCID: PMC3286639          DOI: 10.1016/j.cellimm.2007.07.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  48 in total

1.  Biochemical analysis of activated T lymphocytes. Protein phosphorylation and Ras, ERK, and JNK activation.

Authors:  P E Fields; T F Gajewski
Journal:  Methods Mol Biol       Date:  2000

2.  Long-term survival but impaired homeostatic proliferation of Naïve T cells in the absence of p56lck.

Authors:  B Seddon; G Legname; P Tomlinson; R Zamoyska
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation.

Authors:  Mayumi Naramura; Ihn-Kyung Jang; Hemanta Kole; Fang Huang; Diana Haines; Hua Gu
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

4.  Cbl-b regulates the CD28 dependence of T-cell activation.

Authors:  Y J Chiang; H K Kole; K Brown; M Naramura; S Fukuhara; R J Hu; I K Jang; J S Gutkind; E Shevach; H Gu
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

5.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

6.  Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).

Authors:  M D Griffin; D K Hong; P O Holman; K M Lee; M J Whitters; S M O'Herrin; F Fallarino; M Collins; D M Segal; T F Gajewski; D M Kranz; J A Bluestone
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

Review 7.  The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.

Authors:  Lawrence P Kane; Arthur Weiss
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

Review 8.  Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulation.

Authors:  Christopher E Rudd; Monika Raab
Journal:  Immunol Rev       Date:  2003-04       Impact factor: 12.988

9.  T cell activation in vivo targets diacylglycerol kinase alpha to the membrane: a novel mechanism for Ras attenuation.

Authors:  Miguel A Sanjuán; Bérengère Pradet-Balade; David R Jones; Carlos Martínez-A; James C Stone; Jose A Garcia-Sanz; Isabel Mérida
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 10.  Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.

Authors:  Stefanie Loeser; Josef M Penninger
Journal:  Semin Immunol       Date:  2007-03-27       Impact factor: 11.130

View more
  8 in total

1.  Enhanced T-cell signaling in cells bearing linker for activation of T-cell (LAT) molecules resistant to ubiquitylation.

Authors:  Lakshmi Balagopalan; Benjamin A Ashwell; Kelsie M Bernot; Itoro O Akpan; Naeha Quasba; Valarie A Barr; Lawrence E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapy.

Authors:  Nirali N Shah; Haiying Qin; Bonnie Yates; Ling Su; Haneen Shalabi; Mark Raffeld; Mark A Ahlman; Maryalice Stetler-Stevenson; Constance Yuan; Shuang Guo; Siyuan Liu; Stephen H Hughes; Terry J Fry; Xiaolin Wu
Journal:  Blood Adv       Date:  2019-08-13

3.  Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation.

Authors:  Gregory Driessens; Yan Zheng; Frederick Locke; Judy L Cannon; Fotini Gounari; Thomas F Gajewski
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

Review 4.  T cell receptor gene therapy for cancer.

Authors:  Thomas M Schmitt; Gunnar B Ragnarsson; Philip D Greenberg
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

Review 5.  Molecular regulation of T-cell anergy.

Authors:  Yan Zheng; Yuanyuan Zha; Thomas F Gajewski
Journal:  EMBO Rep       Date:  2008-01       Impact factor: 8.807

6.  Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.

Authors:  Sujit V Janardhan; Kesavannair Praveen; Reinhard Marks; Thomas F Gajewski
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

7.  Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo.

Authors:  Yan Zheng; Yuanyuan Zha; Gregory Driessens; Frederick Locke; Thomas F Gajewski
Journal:  J Exp Med       Date:  2012-11-05       Impact factor: 14.307

8.  The role of E3 ubiquitin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation.

Authors:  Ming-Fang Zhao; Xiu-Juan Qu; Jing-Lei Qu; You-Hong Jiang; Ye Zhang; Ke-Zuo Hou; Hao Deng; Yun-Peng Liu
Journal:  Biomed Res Int       Date:  2013-03-27       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.